These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29123429)

  • 41. Potential drug-drug interactions in prescriptions dispensed in community pharmacies in Greece.
    Chatsisvili A; Sapounidis I; Pavlidou G; Zoumpouridou E; Karakousis VA; Spanakis M; Teperikidis L; Niopas I
    Pharm World Sci; 2010 Apr; 32(2):187-93. PubMed ID: 20077137
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nephrotoxic Medication Exposure in U.S. Adults with Predialysis Chronic Kidney Disease: Health Services Utilization and Cost Outcomes.
    Davis-Ajami ML; Fink JC; Wu J
    J Manag Care Spec Pharm; 2016 Aug; 22(8):959-68. PubMed ID: 27459659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study.
    Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A
    Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of the potential drug-drug interactions between pangenotypic direct-acting antivirals and the concomitant medications associated with patients with chronic hepatitis C virus infection in Spain.
    Sicras Mainar A; Navarro Artieda R; Hernández I; Morillo R
    Gastroenterol Hepatol; 2019 Oct; 42(8):465-475. PubMed ID: 31451229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prescribers' knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers.
    Ko Y; Malone DC; Skrepnek GH; Armstrong EP; Murphy JE; Abarca J; Rehfeld RA; Reel SJ; Woosley RL
    Drug Saf; 2008; 31(6):525-36. PubMed ID: 18484786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study.
    Schlaeppi C; Vanobberghen F; Sikalengo G; Glass TR; Ndege RC; Foe G; Kuemmerle A; Paris DH; Battegay M; Marzolini C; Weisser M;
    HIV Med; 2020 Jan; 21(1):53-63. PubMed ID: 31532898
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinically important drug-drug interactions in primary care.
    Dhabali AA; Awang R; Zyoud SH
    J Clin Pharm Ther; 2012 Aug; 37(4):426-30. PubMed ID: 22081958
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of potential drug - drug interactions in the cardiothoracic intensive care unit patients in a Chinese tertiary care teaching hospital.
    Wang H; Shi H; Wang N; Wang Y; Zhang L; Zhao Y; Xie J
    BMC Pharmacol Toxicol; 2022 Jun; 23(1):39. PubMed ID: 35701808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of Potential Drug-Drug Interactions and Association with Adverse Drug Reactions in Predialysis Chronic Kidney Disease Patients at Indonesian National Referral Hospital.
    Khusfiani T; Soetikno V; Hustrini NM; Nafrialdi N
    Acta Med Indones; 2023 Jul; 55(3):277-284. PubMed ID: 37915149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential drug-drug interactions associated with prolonged stays in the intensive care unit: a retrospective cohort study.
    Moura C; Prado N; Acurcio F
    Clin Drug Investig; 2011; 31(5):309-16. PubMed ID: 21344954
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of potential drug-drug interactions among internal medicine ward in University of Gondar Teaching Hospital, Ethiopia.
    Bhagavathula AS; Berhanie A; Tigistu H; Abraham Y; Getachew Y; Khan TM; Unakal C
    Asian Pac J Trop Biomed; 2014 May; 4(Suppl 1):S204-8. PubMed ID: 25183081
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epidemiology and associated factors of polypharmacy in older patients in primary care: a northern Italian cross-sectional study.
    Piccoliori G; Mahlknecht A; Sandri M; Valentini M; Vögele A; Schmid S; Deflorian F; Engl A; Sönnichsen A; Wiedermann C
    BMC Geriatr; 2021 Mar; 21(1):197. PubMed ID: 33743582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of Drug-Drug Interactions among Critically Ill Patients with Chronic Kidney Disease: Impact of Clinical Pharmacist's Interventions.
    Aghili M; Kasturirangan MN
    Indian J Crit Care Med; 2021 Nov; 25(11):1226-1231. PubMed ID: 34866818
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medication Prescription, Common Side-effects, and Nutritional Status are Associated in Patients With Chronic Kidney Disease.
    Dahl H; Sandblost SRT; Welland NL; Sandnes K; Sekse I; Sæle K; Marti HP; Holst L; Dierkes J
    J Ren Nutr; 2022 Sep; 32(5):520-528. PubMed ID: 34922813
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quality use of medicines in patients with chronic kidney disease.
    Castelino RL; Saunder T; Kitsos A; Peterson GM; Jose M; Wimmer B; Khanam M; Bezabhe W; Stankovich J; Radford J
    BMC Nephrol; 2020 Jun; 21(1):216. PubMed ID: 32503456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Study of drug-drug interactions in prescriptions of general practitioners and specialists in iran 2007-2009.
    Ahmadizar F; Soleymani F; Abdollahi M
    Iran J Pharm Res; 2011; 10(4):921-31. PubMed ID: 24250431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of potential drug-drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex
    Abbas A; Al-Shaibi S; Sankaralingam S; Awaisu A; Kattezhathu VS; Wongwiwatthananukit S; Owusu YB
    Int J Clin Pharm; 2022 Apr; 44(2):348-356. PubMed ID: 34811600
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of two databases to detect potential drug-drug interactions between prescriptions of HIV/AIDS patients in critical care.
    Ramos GV; Guaraldo L; Japiassú AM; Bozza FA
    J Clin Pharm Ther; 2015 Feb; 40(1):63-7. PubMed ID: 25329640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The prevalence of major drug-drug interactions in older adults with cancer and the role of clinical decision support software.
    Nightingale G; Pizzi LT; Barlow A; Barlow B; Jacisin T; McGuire M; Swartz K; Chapman A
    J Geriatr Oncol; 2018 Sep; 9(5):526-533. PubMed ID: 29510896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survey on Polypharmacy and Drug-Drug Interactions Among Elderly People with Cardiovascular Diseases at Yekatit 12 Hospital, Addis Ababa, Ethiopia.
    Assefa YA; Kedir A; Kahaliw W
    Integr Pharm Res Pract; 2020; 9():1-9. PubMed ID: 32021833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.